Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression

Cancer Letters(2021)10.1016/j.canlet.2021.05.006Source: DataRank Database

Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression is a research paper published in Cancer Letters (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

geo gen uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 1.54)OA: hybridTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Eric S. Geanes ORCID,Asona Lui ORCID,Anuradha Roy ORCID,Sean M. Holloran ORCID,Sumedha Gunewardena ORCID

Live enrichment

PubMed:34022283 PMC:PMC8221017 OpenAlex:https://openalex.org/W3162879125

NCI NIH HHS

Grant: F30 CA203160

NIGMS NIH HHS

Grant: P30 GM122731

NIH HHS

Grant: S10 OD023625

NCATS NIH HHS

Grant: TL1 TR001864

National Institutes of Health

Grant: P30 CA118100

NICHD NIH HHS

Grant: U54 HD090216

NIGMS NIH HHS

Grant: P20 GM113117

Department of Defense Peer Reviewed Cancer Research Program

Grant: W81XWH-12-1-0139

NCI NIH HHS

Grant: K01 CA120051

NCI NIH HHS

Grant: P30 CA168524

American Cancer Society

Grant: IRG\u201009\u2010062\u201006

NCI NIH HHS

Grant: R01 CA269286

National Institutes of Health

Grant: U54 HD09216

Intellectual and Developmental Disabilities Research Center

University of Kansas

U.S. Department of Defense

School of Medicine, University of Kansas

University of Kansas Medical Center

FWCI

1.54

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.canlet.2021.05.006

publisherhttps://doi.org/10.1016/j.canlet.2021.05.006

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34022283

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8221017

Fields of Study

interferon and immune responsesCytokine Signaling Pathways and InteractionsCancer-related molecular mechanisms research

MeSH Terms

AdultAgedAnimalsAntigens, DifferentiationCell MovementFemaleHumansMiddle AgedSignal TransductionDown-RegulationGene Expression Regulation, NeoplasticNF-kappa BInterferon-alphaCell Line, TumorCell ProliferationMiceTriple Negative Breast Neoplasms

Keywords

Triple-negative breast cancerCancer researchGene knockdownBiologyDownregulation and upregulationBreast cancerIn vivoCell growthCell cultureCancerNF-kappaBInterferonparthenolideTnbcIfitm1

Sustainable Development Goals

SDG 0: Good health and well-being